COL18A1 and colorectal carcinoma: Several researches showed that endostatin exhibited broad-spectrum antitumor activity in many cancers, such as liver cancer, breast cancer, gastric cancer, and CRC (Ma et al., 2004; Chen et al., 2013; Li et al., 2015).